## **Core Concept**
The most common cause of death in patients on chronic hemodialysis is related to cardiovascular complications. Patients undergoing hemodialysis often have end-stage renal disease (ESRD), which is associated with a high burden of cardiovascular risk factors. These include hypertension, fluid overload, electrolyte imbalances, and the dialysis process itself, which can contribute to cardiovascular stress.

## **Why the Correct Answer is Right**
Cardiovascular disease is the leading cause of death in patients with ESRD on hemodialysis. This is due to several factors:
- **Accelerated atherosclerosis**: The high prevalence of diabetes, hypertension, and dyslipidemia in ESRD patients accelerates atherosclerotic changes.
- **Fluid overload and hypertension**: Chronic fluid overload and hypertension are common in hemodialysis patients and contribute to left ventricular hypertrophy and heart failure.
- **Electrolyte and mineral metabolism disorders**: Abnormalities in calcium and phosphate metabolism can lead to vascular calcification, further increasing cardiovascular risk.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While infections are a significant risk for patients on hemodialysis, especially related to vascular access sites, they are not the most common cause of death compared to cardiovascular disease.
- **Option B:** Although malignancies can be more common in patients with ESRD, they are not the leading cause of death in this population.
- **Option C:** Other causes, including cerebrovascular diseases and liver diseases, contribute to mortality but are less common than cardiovascular disease.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that cardiovascular disease risk management is crucial in patients on chronic hemodialysis. This includes aggressive management of hypertension, optimization of dialysis to reduce fluid overload, and management of mineral metabolism disorders to mitigate vascular calcification.

## **Correct Answer:** . Cardiovascular disease.